Homie Recipes Completes Acquisition of Stevva Ltd. and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
53
Homie Recipes Completes Acquisition of Stevva Ltd. and Enters Rapidly Expanding Global Stevia Market

PELLA GIANNITSA, GREECE--(Marketwired - Aug 21, 2017) - Homie Recipes, Inc. ( OTC PINK : HOMR ) ("Homie" or the "Company"), is pleased to announce the completion of the acquisition of Stevva Ltd. Stevva Ltd. ("STVV") is a Greek company which owns prime farmlands in Pella Giannitsa, Greece. The acquisition allows the Company to focus on the acquired land, which is to grow and cultivate "stevia", a low-carbohydrate food and beverage sweetener, on the newly acquired lands. The new direction of the Company will be led by management with extensive experience and connections in the global stevia marketplace.

Stevia is a low-carbohydrate food and beverage sweetener and sugar substitute. Stevia has absolutely zero-calories and is as much as 300 times sweeter than sugar. Over 80% of stevia is grown and processed in China. For purchasers looking for non-Chinese sourced stevia, the Pella Giannitsa region of Greece has ideal climate and agricultural conditions for producing large quantities of the highest quality stevia.

Pursuant to the completed Share Exchange Agreement, the Company acquired 100% of the issued and outstanding equity of STVV in exchange for an aggregate of 45,000,000 shares of Company common stock. As result of the completed transaction, STVV is now a wholly-owned subsidiary of the Company. Also, pursuant to the completed Share Exchange Agreement, the Company's majority shareholder submitted 39,000,980 shares of its restricted common stock beneficially owned by him for cancellation and were returned to the Company's treasury. Following the completion of the transaction, there are 75,819,000 common shares of the Company issued and outstanding.

As a result of the Share Exchange Agreement, Mr. Theodoros Kerasidis, President and founder of Stevva, Ltd., was appointed a member of the Company's Board of Directors and as the Company's President, Chief Executive Officer, Chief Financial Officer and Secretary. Mr. Jose Mari C. Chin resigned from all positions with the Company.

Mr. Kerasidis is a seasoned agricultural executive and a pioneer in EU stevia growing having founded one of the first ever commercial stevia plantations in Europe. Prior to founding Stevva Ltd. and joining Homie Recipes, Mr. Kerasidis was President of Agricultural Cooperative Stevia (ACS). As President of ACS, he was responsible for the organization which was founded to promote stevia adoption by Greek and EU farmers.

Mr. Kerasidis commented, "We are very pleased to have Homie Recipes acquire 100% of Stevva Ltd. and its land holdings in Greece for growing our future high-quality stevia crops. We look forward to leveraging our extensive experience in stevia production to establish the Company as a global leader in the rapidly expanding market for stevia."

Homie Recipes, Inc. files financial and other regulatory reports with the Securities & Exchange Commission on EDGAR. The Company's filings can be viewed at www.sec.gov .

Cautionary Language Concerning Forward-Looking Statements Some statements in this news release contain forward-looking information or forward-looking statements for the purposes of applicable securities laws. These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include, among others, the timing and completion of contemplated financings, the actual use of proceeds and the receipt of regulatory approvals. In making the forward-looking statements, the Company has applied several material assumptions including, but not limited to, the assumptions that: (1) the proposed corporate development and expansion plans will proceed as planned; (2) market fundamentals will result in sustained commodities pricing and (3) any additional financing needed will be available on reasonable terms. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise except as otherwise required by applicable securities legislation. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to our lack of operating history, transitioning from a development company to an operating company, market acceptance of our products and services; operational difficulties relating to international operations; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the food sector, and our ability to attract and retain qualified personnel. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements.

Contact: Homie Recipes, Inc. / Stevva Ltd. Tel: +30 238-202-6939 E-mail: info@stevva.com Website: www.stevva.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading